CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.
Fiche publication
Date publication
septembre 2018
Journal
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FACY Olivier, Pr ORTEGA DEBALLON Pablo, Pr RAT Patrick
Tous les auteurs :
Santucci N, Facy O, Ortega-Deballon P, Lequeu JB, Rat P, Rat P
Lien Pubmed
Résumé
Surgical resection remains the only curative option for pancreatic adenocarcinoma. Despite recent improvements in medical imaging, unresectability is still often discovered at the time of surgery. It is essential to identify unresectable patients preoperatively to avoid unnecessary surgery. High serum CA 19-9 levels have been suggested as a marker of unresectability but considered inaccurate in patients with hyperbilirubinemia.
Mots clés
CA 19–9, Jaundice, Pancreatic adenocarcinoma, Resectability
Référence
Pancreatology. 2018 Sep;18(6):666-670